32
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effects of Repeated Doses of the Vero Cell Vaccine (SARS-Cov-2 Inactivated Vaccine) on Renal Functions in Balb/C Albino Mice

, , ORCID Icon, , , , & ORCID Icon show all
Pages 2851-2860 | Received 19 Dec 2023, Accepted 20 Apr 2024, Published online: 07 May 2024

References

  • WHO Coronavirus (COVID-19) Dashboard. Available from: https:///covid19.who.int/. Accessed April 23, 2024.
  • Hassanzadeh S, Djamali A, Mostafavi L, Pezeshgi A. Kidney complications following COVID-19 vaccination; a review of the literature. J Nephropharmacol. 2022;11(1):e01. doi:10.34172/npj.2022.01
  • Hotez PJ, Bottazzi ME. Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. Annu Rev Med. 2022;73:55–64. doi:10.1146/annurev-med-042420-113212
  • Jara A, Undurraga EA, González C, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med. 2021;385(10):875–884. doi:10.1056/NEJMoa2107715
  • Tanriover MD, Doğanay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213–222. doi:10.1016/S0140-6736(21)01429-X
  • HHL W, Kalra PA, Chinnadurai R. New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: a Systematic Review. Vaccines. 2021;9(11):1252. doi:10.3390/vaccines9111252
  • Huang Z, Jiang Q, Wang Y, et al. SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats. Food Chem Toxicol. 2021;152:112239. doi:10.1016/j.fct.2021.112239
  • Mancebo A, Casacó A, González B, et al. Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity. Vaccine. 2012;30(22):3329–3338. doi:10.1016/j.vaccine.2012.01.092
  • Sifontes-Rodríguez S, Infante-Bourzac JF, Díaz-Rivero D, et al. Repeated dose toxicity study of a live attenuated oral cholera vaccine in Sprague Dawley rats. Arch Med Res. 2009;40(7):527–535. doi:10.1016/j.arcmed.2009.09.003
  • Stokes A, Pion J, Binazon O, et al. Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats. Regul Toxicol Pharmacol. 2020;113:104648. doi:10.1016/j.yrtph.2020.104648
  • Iwasaki A, Omer SB. Why and How Vaccines Work. Cell. 2020;183(2):290–295. doi:10.1016/j.cell.2020.09.040
  • Leidner AJ, Murthy N, Chesson HW, et al. Cost-effectiveness of adult vaccinations: a systematic review. Vaccine. 2019;37(2):226–234. doi:10.1016/j.vaccine.2018.11.056
  • Qureshi A, Syed Sulaiman SA, Rehman W, Mehmood A, Idrees S, Kumar N. Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan. PLoS One. 2023;18(5):e0285736. doi:10.1371/journal.pone.0285736
  • Norhayati MN, Che Yusof R, Azman YM. Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance. Front Med Lausanne. 2022;8:783982. doi:10.3389/fmed.2021.783982
  • Kumar N, Sulaiman SAS, Hashmi FK, et al. Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination. PLoS One. 2022;17(8):e0270900. doi:10.1371/journal.pone.0270900
  • Jin L, Li Z, Zhang X, Li J, Zhu F. CoronaVac: a review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2. Hum Vaccin Immunother. 2022;18(6):2096970. doi:10.1080/21645515.2022.2096970
  • World Health Organization & WHO Expert Committee on Biological Standardization (‎2013: Geneva, Switzerland); 2014. Available from: https:///apps.who.int/iris/handle/10665/129494. Accessed 30 April 2024.
  • Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc1932
  • Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, Phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–192. doi:10.1016/S1473-3099(20)30843-4
  • Zhang J, Cao J, Ye Q. Renal Side Effects of COVID-19 Vaccination. Vaccines. 2022;10(11):1783. doi:10.3390/vaccines10111783
  • Wang H, Zhang Y, Huang B, et al. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020;182(3):713–721.e9. doi:10.1016/j.cell.2020.06.008